PPD’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
PPD News and Events Media kit
Nicole Stansbury writes about the increasingly important role of change management in clinical research.
International Clinical Trials (February 2017)
John Manns discusses the use of electronic approaches at clinical trial sites.
CenterWatch Monthly (February 2017)
Patricia Hurley, Sarah Jurmeister and Kathryn Parsley discuss this topic from a variety of perspectives, ranging from definitions to strategic considerations and challenges currently faced by developers in this field.
Regulatory Focus (February 2017)
Kirsten Messmer co-authored this article that focuses on the importance of maximizing safety in clinical trials.
Regulatory Rapporteur (February 2017)
FierceBiotech reports on PPD’s early development expansion in Las Vegas.
Fierce Biotech (January 2017)
Cindy Doerfler discusses PPD’s expansion of early development services that are coming with its new Las Vegas operation.
Outsourcing Pharma (January 2017)
Derek Wood talks about the growing importance of extractables/leachables testing. See page 8.
BioPharmaceutical Outsourcing Report (January 2017)
Dirk Reitsma and Austin Combest authored a three-part series as an overview of recent changes to the CLL landscape, as well as future directions to inform practitioners and clinical researchers.
Journal of Hematology Oncology Pharmacy (December 2016)
Mike Gold writes about the importance of smaller studies in drug development.
Scientific American (December 2016)
Marc de Somer and Heather Bryson discuss how sequential parallel comparison design (SPCD) is starting to help control placebo responses.
Nature Reviews Drug Discovery (December 2016)
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.